| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.06 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-07 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |